Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct

摘要

A method for treating ischemia in mammalian species which includes administering a combination of a potassium channel opener such as cromakalim and a compound having a sulfhydryl moiety such as the angiotensin converting enzyme inhibitor zofenopril.